Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Friendly Bacteria Found in Probiotic Drinks May Shrink Solid Tumors

By LabMedica International staff writers
Posted on 15 Apr 2013
Friendly bacteria typically found in probiotic drinks could be used to shrink tumors, according to new research.

Researchers, from the University of Ulster (Northern Ireland) and Sonidel, Ltd. More...
(Dublin, Ireland), examined the effect on tumors of the common Lactobacillus casei, which is found in the gut and human mouth, and a substance used in many probiotic drinks.

When injected directly into tumors, the new findings suggest that L. Casei could suppress tumor growth. Earlier studies suggest that specific kinds of bacteria grow well in solid tumors, which created the potential to use these kinds of bacteria to degrade tumors from the inside out. This study was structured to evaluate the hypothesis using a harmless kind of bacteria—L. Casei was a good candidate.

The researchers cultured the bacteria in beads, inside a growth solution. The research revealed that the bacteria generate molecules that are toxic to tumors. To further assess the hypothesis, the researchers then injected the encapsulated bacteria directly into tumors in lab mice. The bacteria substantially suppressed tumor growth. These research findings suggest that this approach has a potential therapeutic benefit in the treatment of solid tumors.

The study’s findings were published December 2012 in the International Journal of Medical Microbiology.

Related Links:

University of Ulster
Sonidel




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.